NCT07433842

Brief Summary

This study evaluates the efficacy and stability of the "Surgery-First" approach (SF approach) in treating patients with skeletal Class III malocclusion, utilizing a combined retrospective and prospective data collection method. Unlike the conventional method, the SF approach performs orthognathic surgery first to correct the skeletal discrepancy, followed by orthodontic treatment. The study aims to analyze pre-operative dentoskeletal characteristics, arch morphology, and treatment complexity indices, as well as assess the hard and soft tissue changes at 1 week and 1 year post-surgery using digital dental models and Computed Tomography (CT) scans.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

4.1 years

First QC Date

February 19, 2026

Last Update Submit

May 15, 2026

Conditions

Keywords

surgery first orthognathic approachdigital dental modelcomputed tomography3D analysis

Outcome Measures

Primary Outcomes (1)

  • Three-Dimensional Skeletal and Soft Tissue Changes on Computed Tomography (CT)

    Evaluation of dentoskeletal and facial soft tissue changes. The measurements include the three-dimensional (3D) spatial displacement of hard and soft tissue landmarks, as well as angular and linear cephalometric parameters (e.g., SNA, SNB, ANB angles) measured on Computed Tomography (CT) images. Comparisons are made across three time points to assess immediate surgical changes and long-term stability.

    Baseline (T0), 1 week post-surgery (T1), and 12 months post-surgery (T2)

Secondary Outcomes (1)

  • Pre-surgical Dental Arch Characteristics and Treatment Need Indices

    Baseline (T0)

Study Arms (1)

Surgery-First Cohort

EXPERIMENTAL

Patients diagnosed with skeletal Class III malocclusion who undergo the Surgery-First approach.

Procedure: Surgery-First Orthognathic Surgery

Interventions

Orthognathic surgery (Le Fort I, BSSO, or double jaw surgery) performed before orthodontic treatment to correct skeletal discrepancy.

Surgery-First Cohort

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged 16 years or older, and male patients aged 18 years or older.
  • Diagnosis of skeletal Class III malocclusion.
  • Meeting the clinical indications for the Surgery-First orthognathic approach.
  • Treatment plan consensus between the orthodontist and maxillofacial surgeon, aligned with the patient's chief complaint and expectations.
  • Underwent orthognathic surgery using the Surgery-First approach without pre-surgical orthodontic treatment.
  • Good general health, fit for general anesthesia.
  • Voluntarily agreed to participate in the study and provided informed consent.

You may not qualify if:

  • Dentofacial deformities secondary to maxillofacial trauma (e.g., midface retrusion due to Le Fort fractures, or mandibular retrusion due to bilateral condylar fractures).
  • Presence of systemic diseases or conditions that contraindicate general anesthesia or orthognathic surgery.
  • Presence of psychiatric disorders that may compromise treatment cooperation or the informed consent process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hanoi Medical University Hospital

Hanoi, Hanoi, 10000, Vietnam

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Candidate, Lecturer

Study Record Dates

First Submitted

February 19, 2026

First Posted

February 25, 2026

Study Start

March 1, 2022

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data to protect patient privacy and intellectual property before all publications are completed.

Locations